Difficult illnesses such as relapsing chronic skin disease, a global health problem causes an immense amount of physical, mental & emotional disabilities. As per the British Association of Dermatologists, 85% of skin disease suffering gets impacted by psychosocial challenges & dysfunction causing a lot of mental discomfort.
Through psycho neuro-immuno-endocrine & behavioural mechanisms, skin disorders affect the body’s psychological makeup, lowers self control, increases distorted thought processes, affects self esteem, and lower the quality of life.
Provokes fearful anticipation developments, depressive symptoms & reduces psychological well being interest.
Increases psycho-traumatic nature, shamefulness, worthlessness, embarrassment, chances of getting bullied, irritability & short-temperateness. Also reinforces depression, anxiety, social avoidance and loneliness.
Makes patients feel anxious, frustrated with doctors & family members. Increases eagerness to find remedies at any cost. Reduces work productivity, enhances absenteeism from work & expenditure on alternative medicine practitioners, inauthentic treatment methods and advice. Simultaneously initiates sleep disturbances & negatively affects work life balance.
Induces chances of social isolation, loneliness, disturbed quality of life & overall health. Continuous scratching & flaky skin physical appearance ignites depressive, embarrassment, secretiveness, & helpless, stigmatized feelings.
Significantly affects leisure activities, housework & going out for socializing.
Generates shame, depression, anxiety and inferiority complex and attempting to hide hair loss with wigs & hats.
It should include disease related theoretical & practical data & interventions provided by the doctors & caregivers.
Appropriate validation of patient concern right from initial diagnosis of skin disorder.
Availability of correct scientifically driven disease related medical & non medical information, query solving, dissolving misconceptions.
Usage of emollients, creams, and oral medications for management of skin pathology & psychotropic medications to address comorbid psychiatric illnesses.
Creating awareness about the ill effects of stress on skin disease progression & providing simple stress management techniques.
Altering the underlying cognition & understanding the dysfunctional thought processes.
Acceptance and commitment therapy (ACT):
Changing the patient's relationship with their symptoms & strengthening psychological flexibility.
Adding meditation, exercise, and yoga to encourage living in present reality and discouraging strong bonds towards emotional beliefs which causes emotional imbalance and disrupts well-being.
Giving neutral action therapies like awareness training, competing response & positive continuous motivation.
Proactively initiating disease related education, its impact on life & prioritizing various therapeutic options.
Medical fraternity & patient caregivers should always be inquisitive to find, assess & screen mental health disturbances in patients. Simultaneously the patient's detailed orientation regarding skin disease & mental health disturbances should be a part of pre & post routine dermatological interventions.
1.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
2.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
2.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
3.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
4.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
5.
Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation